Boston doctor discusses FDA approval of first RSV vaccine
The FDA decision makes GSK’s shot, called Arexvy, the first of several potential vaccines in the pipeline for RSV to be licensed anywhere.
Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA decision makes GSK’s shot, called Arexvy, the first of several potential vaccines in the pipeline for RSV to be licensed anywhere.
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced its action against the federal government for the uncompensated taking and...
In Amgen Inc v. Sandoz Inc, the Federal Circuit affirmed a district court decision finding two patents covering enantiomerically pure compositions of the psoriasis drug Otezla were valid and one patent covering dosage titration schedule was invalid.
/PRNewswire/ -- 3M Health Care's innovative 3M™ Veraflo™ Therapy, with both 3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse...
/PRNewswire/ -- Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer,...